Biopharma Solutions Tools Tech
Neurotech
Nov 20, 2025
Paradromics has received FDA approval to initiate a clinical study aimed at restoring speech and enabling computer control for individuals with severe motor impairments.
SynBioBeta
2026
May 4-7,
San Jose Convention Center ·
CA, USA
Event Details
Join the innovators shaping the future with SynBio + AI. From health to ag, materials & more—be part of the revolution.
Purchase Pass
Join List
Log In
Sign Up
Subscribe
Insights
Industry News
Multimedia
Events
Advertising
About
Content
Podcast
Video
Categories
Ai Digital Biology
Bio Design
Bioeconomy Policy
Biomanufacturing Scale Up
Biosecurity Bioethics
Capital Markets
Chemicals Materials
Consumer Products
Desci
Engineered Human Therapies
Environment
Food Agriculture
Longevity
Psychedelics
Reading Writing And Editing Dna
Space Exploration
Sponsored Content
Company
Newsletter
Social Media
© Copyright SynBioBeta
Cookie Settings
Privacy Policy
